Correlation Between Avidity Biosciences and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Avidity Biosciences and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avidity Biosciences and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avidity Biosciences and Candel Therapeutics, you can compare the effects of market volatilities on Avidity Biosciences and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avidity Biosciences with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avidity Biosciences and Candel Therapeutics.
Diversification Opportunities for Avidity Biosciences and Candel Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Avidity and Candel is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Avidity Biosciences and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Avidity Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avidity Biosciences are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Avidity Biosciences i.e., Avidity Biosciences and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Avidity Biosciences and Candel Therapeutics
Considering the 90-day investment horizon Avidity Biosciences is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Avidity Biosciences is 4.3 times less risky than Candel Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 457.00 in Candel Therapeutics on December 2, 2024 and sell it today you would earn a total of 441.00 from holding Candel Therapeutics or generate 96.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Avidity Biosciences vs. Candel Therapeutics
Performance |
Timeline |
Avidity Biosciences |
Candel Therapeutics |
Avidity Biosciences and Candel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Avidity Biosciences and Candel Therapeutics
The main advantage of trading using opposite Avidity Biosciences and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avidity Biosciences position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.Avidity Biosciences vs. Revolution Medicines | Avidity Biosciences vs. Black Diamond Therapeutics | Avidity Biosciences vs. Passage Bio | Avidity Biosciences vs. Akero Therapeutics |
Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |